Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Stroke. 2017 May 9;48(6):1636–1645. doi: 10.1161/STROKEAHA.117.016650

Fig 4.

Fig 4

Post-stroke SAG treatment promote the survival of SGZ NSCs in hippocampus. (A) experimental timeline to label SGZ NSCs. (B) YFP+ and (C) YFP+ and DCX+ NSCs and their progeny in contralateral or ipsilateral side of hippocampus in vehicle or SAG-treated mice at 30 days post stroke. (D) Quantification of YFP+, DCX+ cells and percentage of DCX+ cells in YFP+ cells in DG of hippocampus. MEAN± SEM. * p<0.05 compared to contralateral side. # or ##, p<0.05 or p<0.01 compared to vehicle-treated mice, ANOVA. n= 7 each group. scale bar= 100 μm.